Natco Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
1,287.30
651.10
1,434.90
1,410.70
1,110.30
Other Income Qtr Cr66.30176.3063.8048.1042.00
Operating Revenues Qtr1,221.00474.801,371.101,362.601,068.30

*All values are in Cr.

Operating Expenses Qtr
672.90
436.00
566.80
557.80
571.00
Operating Profit Qtr
548.10
38.80
804.30
804.80
497.30
EBITDA Qtr Cr
614.40
215.10
868.10
852.90
539.30
Depreciation Qtr
98.30
47.00
45.80
44.10
55.50
Net Profit Qtr
406.60
133.00
677.30
668.50
386.30
Basic EPS Qtr
22.70
7.43
37.81
37.32
21.56
Open Demat Account
+91 -

Open Demat Account
+91 -